iShares Genomics Immunology and Healthcare ETF is a ETF series of iShares Trust (series S000065599). Net assets $160.5M as of 2026-04-30. Index fund.
Showing 15 of 63 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | — | $33.7M | 2098.30% |
| REVOLUTION MEDICINES, INC. | — | $11.0M | 685.45% |
| MODERNA, INC. | — | $10.1M | 628.19% |
| IPSEN SA | — | $8.4M | 523.93% |
| Bayer Aktiengesellschaft | — | $7.0M | 437.79% |
| Takeda Pharmaceutical Company Limited | — | $6.8M | 421.87% |
| MERCK & CO., INC. | — | $6.7M | 414.71% |
| GSK PLC | — | $6.6M | 412.34% |
| BioNTech SE | — | $6.5M | 407.11% |
| Roche Holding AG | — | $6.4M | 399.28% |
| EXELIXIS, INC. | — | $6.1M | 379.63% |
| Twist Bioscience Corp | — | $6.1M | 378.56% |
| REGENERON PHARMACEUTICALS, INC. | — | $6.0M | 372.83% |
| SANOFI SA | — | $5.7M | 358.00% |
| VERTEX PHARMACEUTICALS INCORPORATED | — | $5.7M | 355.40% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $160.5M |
| 2026-01-31 | $142.8M |
| 2025-10-31 | $128.2M |
| 2025-07-31 | $109.1M |
| 2025-04-30 | $111.8M |
| 2025-01-31 | $123.1M |
| 2024-10-31 | $137.8M |
| 2024-07-31 | $140.4M |